Skip to main content

Table 1 Baseline characteristics and outcome of COVID-19 patients within the COVID-19 care team

From: Surgeons’ involvement in COVID-19 treatment: a practice by a regional core hospital in Japan to avoid physician burnout

Variables

Affiliation of treating doctor

P value

Surgeon (n = 43)

Other surgeona (n = 24)

Internist (n = 93)

Age, years

82 (62 - 92)

87 (16 - 103)

82 (49 -101)

.405

Age ≥ 80 years

27 (62.8%)

17 (70.8%)

55 (59.1%)

.565

Sex, female

21 (48.8%)

18 (75%)

46 (49.5%)

.065

Comorbidities

 Hypertention

24 (55.8%)

11 (45.8%)

56 (60.2%)

.434

 Diabetes mellitus

14 (32.6%)

7 (29.2%)

28 (30.1%)

.970

 Heart disease

8 (18.6%)

6 (25.0%)

21 (22.6%)

.772

 Cerebrovascular disease

5 (11.6%)

3 (12.5%)

16 (17.2%)

.743

 Chronic pulmonary disease

6 (14.0%)

2 (8.3%)

8 (8.6%)

.569

 Chronic kidney disease

2 (4.7%)

3 (12.5%)

5 (5.4%)

.391

 Active malignancy

3 (7.0%)

1 (4.2%)

5 (5.4%)

.890

 Body mass index ≥30 kg/m2

0 (0%)

1 (4.2%)

3 (3.2%)

.473

 Active immunosuppresion

1 (2.3%)

0 (0%)

4 (4.3%)

.837

 Dementia

13 (30.2%)

13 (54.2%)

29 (31.2%)

.098

Severity

   

.376

 Mild

6 (14.0%)

2 (8.3%)

10 (10.7%)

 

 Moderate

3 (7.0%)

5 (20.8%)

6 (6.5%)

 

 Severe

16 (37.2%)

11 (45.8%)

44 (47.3%)

 

 Critical

18 (41.8%)

6 (25.0%)

33 (35.5%)

 

Coinfection

8 (18.6%)

7 (29.2%)

28 (30.1%)

.352

Hospital stay, days

14 (1 - 53)

14 (3 - 41)

15 (1 - 69)

.937

Outcomes

 Discharge to home

15 (34.9%)

11 (45.8%)

33 (35.5%)

.626

 Transfer for rehabilitation

13 (30.2%)

6 (25.0%)

26 (28.0%)

.910

 Transfer to advanced care facility

0 (0%)

1 (4.2%)

5 (5.4%)

.287

 Death

15 (34.9%)

6 (25.0%)

29 (31.2%)

.722

  1. Continuous variables are presented as medians (ranges). Categorical variables are presented as numbers and percentages
  2. aUrology, Dermatology, Otorhinolaryngocology, Orthopedics